The effects of liraglutide on male fertility: A case report
The picture from real-world post-market safety monitoring has been more serious: on January 29, 2026, the UK MHRA strengthened its pancreatitis warning for all GLP-1 and dual GLP-1/GIP medications to explicitly include necrotizing and fatal cases, based on reported cases since market approval
Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, et al
[10] Upon administration, the medication binds to specific growth hormone receptors located on the surface of target cells throughout the body, particularly in the liver, muscle, and bone tissues
5H, malondialdehyde (MDA) content was significantly increased in the VPA group compared to controls ( P 0.05 )